Moderna received FDA Fast Track Designation for Respiratory Syncytial Virus vaccine
On Aug. 3, 2021, Moderna announced that the U.S. Food and Drug Administration (FDA) had granted Fast Track…
Vaxart reported boosting immune responses in subjects previously vaccinated by a Vaxart vaccine
On Jul. 29, 2021, Vaxart announced that it had shown for the first time in clinical trials that…
Oxford vaccine reached one billion doses released
On Jul. 29, 2021, the University of Oxfordï¾’s and AstraZeneca announced that one billion doses of the ChAdOx1…
COVID-19 vaccine delivered into nose of research animals reduced nasal virus shedding
On Jul. 27, 2021, the National Institutes of Health announced that the COVID-19 vaccine AZD1222, when delivered into…
Oragenics entered into licensing agreement with the NRC of Canada, to pursue next-generation SARS-CoV-2 vaccines
On Jul. 27, 2021, Oragenics announced it had entered into a licensing agreement with the National Research Council…
Phase I trial began of new vaccine against the Plague
On Jul. 26, 2021, researchers at the University of Oxford launched a Phase 1 trial to test a…
Gavi signed agreements with Sinopharm and Sinovac for immediate supply to COVAX
On Jul. 12, 2021, Gavi, the Vaccine Alliance, announced that it had signed advance purchase agreements with Sinopharm…
HDT Bio received notice to proceed from FDA for U.S. phase 1 clinical trial of RNA COVID-19 vaccine
On Jul. 1, 2021, HDT Bio announced the U.S. Food and Drug Administration had reviewed the companyï¾’s Investigational…
Novavax published results of UK phase 3 clinical trial in NEJM, demonstrating high levels of efficacy of COVID-19 vaccine
On Jun. 30, 2021, Novavax announced the publication of results from the final analysis of a pivotal Phase…
VBI Vaccines announced initial positive phase 1 data for its eVLP vaccine candidate against COVID-19
On Jun. 29, 2021, VBI Vaccines announced positive Phase 1 data from its Phase 1/2 trial of the…
NIH began sudy of COVID-19 vaccination during pregnancy and postpartum
On Jun. 23, 2021, the National Institutes of Health announced that an observational study had begun to evaluate…
RECOVERY trial found Regeneron’s monoclonal antibody combination reduced deaths for hospitalised COVID-19 patients
On Jun. 16, 2021, the University of Oxford announced the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial demonstrated…
KPWHRI announced volunteers needed for COVID-19 vaccine-booster trial
On Jun. 16, 2021, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that was recruiting volunteers in the…
Cocrystal’s COVID-19 antiviral CDI-45205 shown to be active against SARS-CoV-2 and prominent SARS-CoV-2 variants
On Jun. 14, 2021, Cocrystal Pharma announced the selection of CDI-45205 as the lead compound for further development…
Novan announced positive ppreclinical data in SB019 COVID-19 anti-viral therapy program
On Jun. 10, 2021, Novan announced positive preclinical results with berdazimer sodium in a SARS-CoV-2 transmission model in…
NIH launched clinical trial of universal influenza vaccine candidate
On Jun. 1, 2021, a first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle…
Sanofi and Parkinson’s Foundation collaborated to advance availability of free genetic testing and counseling for people with Parkinson’s disease
On Jun. 1, 2021, Sanofi announced that Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus…
U.S. blood donations declared safe under current COVID-19 screening guidelines
On Jun. 1, 2021, a study by researchers at the National Institutes of Health and their colleagues found…
Oregon required all captive mink vaccinated against SARS-CoV-2
On May 28, 2021, the Oregon Department of Agriculture (ODA) lifted the quarantine on the Oregon mink farm…
Patient enrollment reached 90 percent in Innovation Pharmaceuticals phase 2 clinical trial of Brilacidin for COVID-19
On May 27, 2021, Innovation Pharmaceuticals announced that patient enrollment in the Companyï¾’s 120-patient, Phase 2 clinical trial…
Seattle Children’s researchers discovered that functional COVID-19 antibodies are lost quickly after mild cases
On May 27, 2021, Seattle Children’s researchers published a study that uncovered a deeper understanding of why people…
Altimmune demonstrated strong neutralization of South African variant in preclinical study of intranasal AdCOVIDï¾™
On May 26, 2021, Altimmune announced new results from a preclinical study demonstrating the ability of its AdCOVID…
Disease | Life Science News | Vaccine | WHO
WHO and Switzerland launched global BioHub for pathogen storage, sharing and analysis
On May 24, 2021, the World Health Organization (WHO) and the Swiss Confederation signed a Memorandum of Understanding…
Health Canada approved Quidel’s Sofia’ SARS antigen FIA test for screening asymptomatic populations
On May 24, 2021, Quidel announced that its Sofia’ SARS Antigen FIA was the first rapid antigen test…
Labcorp study suggested COVID-19 antibodies remain at least 10 months after infection
On May 24, 2021, LabCorp reported that nearly 87% of naturally infected COVID-19 patients maintained antibodies to SARS-CoV-2…
G20 leaders boosted support of the Access to COVID-19 Tools Accelerator
On May 21, 2021, world leaders the Global Health Summit adopted an agenda to overcome the COVID-19 pandemic,…
Scientists discovered rare genetic condition that attacks kidsï¾’ immune systems
On May 19, 2021, Megan A. Cooper, MD, PhD, an associate professor of pediatrics at Washington University School…
GSK and Vir Biotechnology announced start of the EMA rolling review of VIR-7831 (sotrovimab) for early treatment of COVID-19
On May 7, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agency (EMA) has started a…
Hoth Therapeutics and Virginia Commonwealth University expanded research agreement for COVID-19 therapeutic
On May 5, 2021, Hoth Therapeutics announced it has expanded its sponsored research agreement with Virginia Commonwealth University…
The 12th Ebola outbreak in the Democratic Republic of the Congo declared over
On May 3, 2021, the World Health Organization (WHO) announced the end of the 12th outbreak of Ebola…